Cargando…
PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431412/ http://dx.doi.org/10.1097/01.HS9.0000851292.41035.e8 |
| _version_ | 1784780048105996288 |
|---|---|
| author | Borchmann, P. Vandenberghe, P. Urbano, A. Haioun, C. Lemonnier, F. Griškevicius, L. Maury, S. Holtkamp, S. Friedrichs, B. Zadoyan, G. Hanssens, L. Brillant, C. Bethke, U. Assenmacher, M. Bürger, I. Philippe, B. Overstijns, T. Jäger, U. Kersten, M. J. |
| author_facet | Borchmann, P. Vandenberghe, P. Urbano, A. Haioun, C. Lemonnier, F. Griškevicius, L. Maury, S. Holtkamp, S. Friedrichs, B. Zadoyan, G. Hanssens, L. Brillant, C. Bethke, U. Assenmacher, M. Bürger, I. Philippe, B. Overstijns, T. Jäger, U. Kersten, M. J. |
| author_sort | Borchmann, P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431412 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94314122022-08-31 PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION Borchmann, P. Vandenberghe, P. Urbano, A. Haioun, C. Lemonnier, F. Griškevicius, L. Maury, S. Holtkamp, S. Friedrichs, B. Zadoyan, G. Hanssens, L. Brillant, C. Bethke, U. Assenmacher, M. Bürger, I. Philippe, B. Overstijns, T. Jäger, U. Kersten, M. J. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431412/ http://dx.doi.org/10.1097/01.HS9.0000851292.41035.e8 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Borchmann, P. Vandenberghe, P. Urbano, A. Haioun, C. Lemonnier, F. Griškevicius, L. Maury, S. Holtkamp, S. Friedrichs, B. Zadoyan, G. Hanssens, L. Brillant, C. Bethke, U. Assenmacher, M. Bürger, I. Philippe, B. Overstijns, T. Jäger, U. Kersten, M. J. PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title | PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title_full | PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title_fullStr | PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title_full_unstemmed | PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title_short | PB2115: TRIAL IN PROGRESS: A RANDOMIZED PHASE II STUDY OF MB-CART2019.1 COMPARED TO STANDARD OF CARE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY DLBCL INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION |
| title_sort | pb2115: trial in progress: a randomized phase ii study of mb-cart2019.1 compared to standard of care therapy in patients with relapsed/refractory dlbcl ineligible for autologous stem cell transplantation |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431412/ http://dx.doi.org/10.1097/01.HS9.0000851292.41035.e8 |
| work_keys_str_mv | AT borchmannp pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT vandenberghep pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT urbanoa pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT haiounc pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT lemonnierf pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT griskeviciusl pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT maurys pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT holtkamps pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT friedrichsb pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT zadoyang pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT hanssensl pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT brillantc pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT bethkeu pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT assenmacherm pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT burgeri pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT philippeb pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT overstijnst pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT jageru pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation AT kerstenmj pb2115trialinprogressarandomizedphaseiistudyofmbcart20191comparedtostandardofcaretherapyinpatientswithrelapsedrefractorydlbclineligibleforautologousstemcelltransplantation |